Search

The Division's research has had a longstanding focus on understanding health disparities across the continuum of care. The Division's portfolio includes work that identifies groups at risk for health disparities and studies that try to understand the mechanisms that underlie these disparities. This...

Maxime Lebaz-Dubosq, MD - September 2025 Azariah Boyd, MS - July 2025 Christopher Koo, MRCP, MCI - July 2025 Daniel Johnson, BA - June 2025 Frank Medina, BA - April 2025

The Beth Israel Deaconess Transgenic Core Facility opened in October of 1991. The first transgenic mouse created in the facility was born in January of 1992. In 1994 the Core became the Cohen-Solomon transgenic laboratory. The Transgenic Core is a state-of-art facility that produces genetically...

Neurotransmitter sensing is important for both fundamental understanding and clinical treatment of many diseases and conditions, including Alzheimer’s disease, obsessive-compulsive disorder, depression, and drug addiction, which not only create a huge economic burden in our society but also induce...

OSEE works with Departments across BILH (and outside of the system) to create and lead professional development workshops, designed to support your personal and professional growth while carrying out your research experience. These are led by OSEE staff, BILH Researchers, and external speakers...

Available by appointment M-F 10am-12pm. Sign-up available through requests tab in iLabs. CytoFLEX LX and Aurora Procedures Only previously trained by staff researchers are allowed to operate and book the analyzers. You are billed according to the time booked. Therefore, please book the time...

Please Cite Us As: Beth Israel Deaconess Medical Center - BIDMC-Flow Cytometry Core and MassNano nanoparticle facility, RRID:SCR_012305 Publications Utilizing Our Services: 1.) Tran V, de Oliveira-Jr GP, Chidester S, Lu S, Pleet ML, Ivanov AR, Tigges J, Yang M, Jacobson S, Gonçalves MCB, Schmaier AA...